COVID-19 Vaccination For Children

Summary of Recommendations

• ATAGI recommends COVID-19 vaccination for children aged 6 months to <5 years with severe immunocompromise, disability, and those who have complex and/or multiple health conditions which increase the risk of severe COVID-19. These include children with the following or similar conditions:

  • Severe primary or secondary immunodeficiency, including those undergoing treatment for cancer, or on immunosuppressive treatments as listed in the ATAGI advice on 3rd primary doses of COVID-19 vaccine in individuals who are severely immunocompromised;

  • Bone marrow or stem cell transplant, or chimeric antigen T-cell (CAR-T) therapy;

  • Complex congenital cardiac disease;

  • Structural airway anomalies or chronic lung disease;

  • Type 1 diabetes mellitus;

  • Chronic neurological or neuromuscular conditions; or

  • A disability that requires frequent assistance with activities of daily living, such as severe cerebral palsy or Down Syndrome (Trisomy 21).

• The recommendation is for 2 primary doses, except for those with severe immunocompromise who require 3 primary doses. The recommended interval between each dose is 8 weeks.